UCLA scientists engineer ready-to-use cancer-fighting T cells for solid tumors
On Sept. 8, 2026, researchers from the University of California, Los Angeles (UCLA) announce they have developed a…
On Sept. 8, 2026, researchers from the University of California, Los Angeles (UCLA) announce they have developed a…
On Jan. 8, 2026, for the first time, researchers at the University of British Columbia have demonstrated how…
On Jun. 25, 2018, AbbVie, a research-based global biopharmaceutical company, and Calibr, a nonprofit drug discovery division of…
On Jun. 18, 2008, Fred Hutch researchers described the first successful use of a human patient’s cloned infection-fighting…
On Mar. 8, 1984, two articles describing the cloning of the T-Cell Receptor (TCR) by Tak Wah Mak…